Keyphrases
Mouse Model
100%
Neurofibromatosis Type 1 (NF-1)
100%
Glioma
100%
Cyclic Adenosine Monophosphate (cAMP)
100%
Gliomagenesis
100%
Brain Regions
33%
Mouse Strain
33%
Genetically Engineered Mice
33%
Phosphodiesterase
33%
Leukocytes
16%
Oncogenic Pathways
16%
Cortex
16%
Central Nervous System
16%
Targeted Therapy
16%
Aging
16%
Fibroblasts
16%
Oncogenesis
16%
Chronic Inflammation
16%
Pharmacologic
16%
Tumor Size
16%
Tumorigenesis
16%
Young children
16%
Mouse in Vivo
16%
Genetically Engineered Mouse Models
16%
Optic Pathway Glioma
16%
Tumor Formation
16%
Glioma Growth
16%
Brain Tumor
16%
Microenvironment
16%
Forced Expression
16%
Glioma Tumor
16%
Specific Difference
16%
Spatial Restriction
16%
Optic Pathway
16%
Rolipram
16%
PDE4 Inhibitor
16%
Medicine and Dentistry
Neurofibromatosis Type I
100%
Ganglioglioma
100%
Cyclic AMP
100%
Carcinogenesis
50%
Brain Region
33%
Phosphodiesterase
33%
Neoplasm
16%
Stroma
16%
Leukocyte
16%
Targeted Therapy
16%
Chronic Inflammation
16%
Toddlers
16%
Central Nervous System
16%
Optic Nerve Glioma
16%
Intracranial Tumor
16%
Phosphodiesterase IV Inhibitor
16%
Rolipram
16%
Fibroblast
16%
Neuroscience
Neurofibromatosis Type 1
100%
Cyclic Adenosine Monophosphate
100%
Carcinogenesis
37%
Phosphodiesterase
25%
Leukocyte
12%
Central Nervous System
12%
In Vivo
12%
Rolipram
12%
Phosphodiesterase-4 Inhibitor
12%
Intracranial Tumor
12%
Fibroblast
12%